A
TCRT
Alaunos Therapeutics, Inc
2.420
+0.050+2.11%After Hours: 2.560 +0.140 +5.78%19:59 05/22 EDT
OPEN/PREV CLOSE2.450/2.370
TODAY RANGE2.400-2.550
VOL15.11K
MARKET CAP59.10M
52 WEEK RANGE1.670-6.20
AVG VOL (3M)15.62K
% TURNOVER0.06%
TURNOVER--
P/E (TTM)-1.1758
% RANGE6.75%
EPS(TTM)-2.0581
P/E(FORWARD)-0.1241
P/B4.469
BVPS0.5415
DIVIDEND--
P/S1,152.38
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP58.28M
SHARES OUTSTANDING24.42M
NEXT EARNINGS08/12-08/17
FREE FLOAT24.08M
LOT SIZE1
EX-DATE07/18/2024
News
Press Releases
Financial Reports
Profile
TipRanks·5d ago
Alaunos Highlights New Preclinical Data for Obesity Therapy
TipRanks·05/04 20:42
Valion Bio names Melinda Lackey as General Counsel
Dow Jones·05/04 20:05
Press Release: Valion Bio Appoints Melinda Lackey as General Counsel
Benzinga·04/21 21:05
12 Health Care Stocks Moving In Tuesday's After-Market Session
TipRanks·04/15 21:18
Alaunos Therapeutics Faces Nasdaq Non-Compliance, Delisting Risk
Reuters·03/02 18:55
BUZZ-U.S. STOCKS ON THE MOVE-Gitlab, ADT Inc, California Resources
Benzinga·03/02 16:47
Weight Loss Data From Obese Mice Looks Promising For Alaunos Therapeutics, But Shares Drop
Reuters·03/02 14:18
BUZZ-U.S. STOCKS ON THE MOVE -Duolingo, AES, NextDecade